Atlas Trials

Alternative Dosing And Prevention of Transfusions (ADAPT)

Clinical trial NCT05662098 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05662098
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2022-06-16
Primary completion
2026-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.